Advertorial: Celebrating 40 Years of Leadership & Innovation with Galderma
2021 is a milestone year for global aesthetics leader Galderma, who celebrate their 40th anniversary this year.
2021 is a milestone year for global aesthetics leader Galderma, who celebrate their 40th anniversary this year.
Global pharmaceutical company Galderma has received top-line results for its phase 2 study in the US on the efficacy and safety of a single dose of abobotulinumtoxinA versus placebo for the treatment of moderate to severe glabellar lines.
A new study published in Plastic and Reconstructive Surgery has suggested that intradermal botulinum toxin injection, or microbotulinum, is a safe and effective method to treat skin flaws.
According to a report published by Fortune Business Insights, the botulinum toxin market will reach US $8,309 million by 2026, exhibiting a compound annual growth rate of 8%.
The Advertising Standards Authority (ASA) has provided practitioners with further advice for social media advertising to avoid having their adverts removed for not complying with the Enforcement Notice published in January.
Aesthetics reports on today’s update from Parliament
A new report on the regulation of cosmetic treatments in the UK has been released urging the Department of Health and Social Care (DHSC) to introduce legislation that requires mandatory licensing of all cosmetic treatments.
Aesthetic training provider Cosmetic Courses is introducing a new Level 7 Diploma in Clinical Aesthetic Injectable Treatments.
Aesthetic practitioner Dr Tapan Patel has launched a new aesthetic training academy, PHI College.
Research published in Scientific Reports journal has suggested that botulinum toxin (BoNT-A) could be used as an effective treatment for patients with depression.